Genelux Corp GNLX IPO will take place January, 26 on the NASDAQ exchange under the ticker GNLX.
The company is offering shares at an expected price between $6.00 and $7.00 per share with an insider lock-up period of 180 days ending on July 25, 2023.
See also: Benzinga IPO Calendar
About Genelux Corp
Genelux is a clinical-stage biopharmaceutical company focused on developing a pipeline of next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: IPOsBZI-IPOPreview